A prediction model for overall survival after transarterial chemoembolization for hepatocellular carcinoma invading the hepatic vein or inferior vena cava-Reference-Cited by-同舟云学术

A prediction model for overall survival after transarterial chemoembolization for hepatocellular carcinoma invading the hepatic vein or inferior vena cava

Published:2020-11-26 Issue:6 Volume:31 Page:4232-4242
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Chu Hee Ho,Chun Seng-Yong,Kim Jin Hyoung^ORCID,Kim Pyeong Hwa,Il Gwon Dong,Ko Heung-Kyu,Kim Nayoung

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-020-07536-8.pdf

Reference44 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

2. European Association for The Study of The Liver; European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943

3. Pawlik TM, Poon RT, Abdalla EK et al (2005) Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137:403–410

4. Kim JH, Shim JH, Yoon HK, Ko HK, Kim JW, Gwon DI (2018) Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein. Liver Int 38:1646–1654

5. Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma with macrovascular invasion: need a personalized medicine for this complicated event;Hepatobiliary Surgery and Nutrition;2024-02

2. Intermediate-stage (BCLC stage B) infiltrative hepatocellular carcinoma: safety and efficacy of chemoembolization;European Radiology;2023-07-19

3. Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-02

4. Review of outcomes of combination therapy using yttrium 90 radioembolization and sorafenib/nivolumab for HCC with hepatic vein or IVC invasion;Proceedings of Singapore Healthcare;2023-01-28

5. Pulmonary embolism as the first sign of hepatocellular carcinoma in a patient who was cured after five years;Eurasian Journal of Pulmonology;2023